Clinical Trial Update: Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial evaluated the safety and preliminary efficacy of the NeuroFlo device in patients who had a stroke 8 to 24 hours prior to treatment; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• NeuroFlo

Snippet

Sponsor: CoAxia | Conditions: Cerebrovascular Accident | Phase 1 | Status: COMPLETED